article thumbnail

Wake Network Retains CRO Santé Cannabis to Conduct Clinical Trials in Psilocybin Therapies

Cannabis Law Report

This engagement will build on the strong foundation on Santé, having treated more than 10,000 patients since 2014 under a real-world data protocol. We are excited to explore the potential of emergent psychedelic therapies. ABOUT SANTÉ CANNABIS.

article thumbnail

Press Release: MindMed Engages in Pre-Submission Meeting with FDA for Development of the MindMed Session Monitoring System

Cannabis Law Report

These describe technology and infrastructure for the collection of precise, multimodal, multivalent data that can be processed via machine learning, artificial intelligence, signal processes, and other statistical methods to yield clinically meaningful output to satisfy the requirements of the IFU. NEW YORK , Dec. ” About MindMed.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Applied DNA Advances Cotton Genomics-based Methodology for Determination of Authenticity and Provenance

Cannabis Law Report

The Company recently presented initial data describing a methodology and findings for the successful determination of Egyptian cotton fiber, yarn and fabric origin using the combination of cotton genomics and isotopic analysis (IA) at an American Apparel and Footwear Association event.

article thumbnail

Applied DNA Reports Veterinary COVID-19 Vaccine Candidate Induces Neutralizing Antibodies in 100% of Trial Cohort Against B.1.1.7, P1, and B.1.526 Variants and Sets August 2021 Mink Challenge Trial Launch

Cannabis Law Report

1.526 were reduced as expected and consistent with other CDC-reported data on vaccine-induced antibody neutralization against these variants 1. The study showed neutralizing antibody titers against B.1.1.7 were not significantly impacted, while neutralizing antibody titers against P1 and B.1.526 Dr. James A.

article thumbnail

GW Pharmaceuticals receives approval for EPIDYOLEX® (cannabidiol) from the MHRA for the treatment of seizures associated with tuberous sclerosis complex

Cannabis Law Report

GW was initially granted marketing authorisation for this medicine in the UK in September 2019 as an adjunctive therapy for seizures associated with Lennox Gastaut syndrome (LGS) or Dravet syndrome, in conjunction with clobazam, for patients two years of age and older. The natural history of epilepsy in tuberous sclerosis complex.

article thumbnail

Research Publication Demonstrates Utility of Applied DNA’s LinearDNA™ in Non-Viral CAR T Manufacturing Systems

Cannabis Law Report

We find LinearDNA to be an excellent platform for CAR T-cell therapy development.”. These manufacturing complexities have likewise hindered research on CAR T-cell therapies. Dr. James A. About Applied DNA Sciences.

article thumbnail

The Queer Cannabis Club and Culture

Veriheal

Rechsteiner, a transgender man who expressed the following regarding how cannabis helped him throughout his transition with hormone replacement therapy. “In During my transition with hormone replacement therapy I was smoking, as it lifts your mood fairly quickly. This was a pivotal aspect of cannabis legalization history.

Therapy 82